Daito Pharmaceutical Co.,Ltd. (TYO:4577)

Daito Pharmaceutical Revenue

Daito Pharmaceutical had revenue of 11.59B JPY in the quarter ending February 28, 2026, a decrease of -3.61%. This brings the company's revenue in the last twelve months to 50.77B, up 3.94% year-over-year. In the fiscal year ending May 31, 2025, Daito Pharmaceutical had annual revenue of 50.64B with 7.99% growth.

• Revenue (ttm): 50.77B
• Revenue Growth: +3.94%
• P/S Ratio: 0.77
• Revenue / Employee: 47.31M
• Employees: 1,073
• Market Cap: 39.09B

Revenue History

Fiscal Year End	Revenue	Change	Growth
May 31, 2025	50.64B	3.75B	7.99%
May 31, 2024	46.90B	1.79B	3.98%
May 31, 2023	45.10B	1.64B	3.77%
May 31, 2022	43.46B	-5.25B	-10.78%
May 31, 2021	48.71B	3.72B	8.27%